Cyclerion Therapeutics annual capital expenditures (capex)
2018
2019
2020
2021
2022
Cyclerion Therapeutics Capital Expenditures (CapEx) Growth & History (CYCN)
Cyclerion Therapeutics's capital expenditures (capex) was $0 for fiscal 2022.
View full Cyclerion Therapeutics company overviewCyclerion Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $0 | −$7,000 | — |
| 2021 | 2021-12-31 | $7,000 | −$1.5M | −99.54% |
| 2020 | 2020-12-31 | $1.5M | −$5.4M | −77.87% |
| 2019 | 2019-12-31 | $6.9M | $3.5M | +100.35% |
| 2018 | 2018-12-31 | $3.4M | — | — |
Cyclerion Therapeutics quarterly capital expenditures (capex)
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $66,000 | $66,000 | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2020 | 2020-12-31 | $35,000 | −$139,000 | −79.89% |
| Q3 2020 | 2020-09-30 | $9,000 | −$644,000 | −98.62% |
| Q2 2020 | 2020-06-30 | $75,000 | −$4.2M | −98.23% |
| Q1 2020 | 2020-03-31 | $1.4M | −$409,000 | −22.55% |
| Q4 2019 | 2019-12-31 | $174,000 | −$1.6M | −90.42% |
| Q3 2019 | 2019-09-30 | $653,000 | −$507,000 | −43.71% |
| Q2 2019 | 2019-06-30 | $4.2M | $3.9M | +1315.67% |
| Q1 2019 | 2019-03-31 | $1.8M | $1.7M | +1019.75% |
| Q4 2018 | 2018-12-31 | $1.8M | — | — |
| Q3 2018 | 2018-09-30 | $1.2M | — | — |
| Q2 2018 | 2018-06-30 | $300,000 | — | — |
| Q1 2018 | 2018-03-31 | $162,000 | — | — |
Cyclerion Therapeutics capital expenditures (capex) trends
Between the periods ended 2018-12-31 and 2022-12-31, Cyclerion Therapeutics's capital expenditures (capex) decreased from $3.4M to $0, a change of −$3.4M. The latest reported quarter, Q2 2026, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cyclerion Therapeutics source filings ↗